A recent survey conducted by professional consulting firm Gallup has revealed that approximately 61% of Americans believe that regulations pertaining to electronic cigarettes should be stricter. More than half of Republicans, Independents, and Democrats support the implementation of more rigid laws.
Source: Andrey Popov
The Gallup annual consumer survey was conducted from July 5th to July 26th, following the FDA's ban on JUUL in the United States.
Currently, 61% of Americans support stricter regulations on electronic cigarettes, slightly higher than the 54% who held this view last year but similar to the 64% in 2019. A public opinion survey also found that most Americans support a ban on nicotine in cigarettes rather than menthol.
Statement:
This article was compiled from third-party information and is intended for industry exchange and learning.
This article does not represent the views of 2FIRSTS, and 2FIRSTS is also unable to confirm the authenticity and accuracy of the article's content. The compilation of this article is solely intended for industry exchange and research purposes.
Due to limitations in the translation quality, the translated article may not fully reflect the original text. Please refer to the original text as the definitive source.
For any domestic, Hong Kong, Macao and Taiwan-related, and foreign-related statements and positions, 2FIRSTS fully aligns with the Chinese government.
The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
